An international working group led by the German Society for Infectious Diseases (DGI) has developed a guideline for personalized phage therapy. Twenty professional organizations, 18 international experts, including representatives from regulatory agencies, and two patient advocacy organizations were involved.
First Global Guideline Established for Personalized Phage Therapy in Hard-to-Treat Infections
An international working group led by the German Society for Infectious Diseases has established the first global guideline for personalized phage therapy, involving 20 professional organizations and 18 international experts. This development is significant as it could enhance treatment options for hard-to-treat infections in Iran, where antibiotic resistance is a growing concern.
👥 Key Players
📰 What Happened
An international working group has established the first global guideline for personalized phage therapy, aimed at treating hard-to-treat infections. This guideline was developed with input from various professional organizations and experts.
- The guideline involves 20 professional organizations and 18 international experts.
- It addresses the growing issue of antibiotic resistance, particularly relevant for countries like Iran.
💡 Why It Matters
📚 Background
Phage therapy uses bacteriophages to target and kill bacteria, offering a potential solution to antibiotic resistance. This is particularly relevant as traditional antibiotics become less effective.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%